文献速递产科麻醉疼痛医学

他喷他多与羟考酮在腹腔镜子宫切除术后镇痛及副作用比较:随机对照试验

Tapentadol versus oxycodone analgesia and side effects after laparoscopic hysterectomy: A randomised controlled trial.
PubMed 文献 · Eur J Anaesthesiol · 2021-01-01

结果显示两组术后24小时静息及咳嗽时疼痛评分无显著差异, rescue 药物剂量相似,但他喷他多组术后2和3小时恶心发生率显著更低且止吐药需求更少。

要点

  • 他喷他多与羟考酮在腹腔镜子宫切除术后24小时镇痛效果相当。
  • 他喷他多组术后2和3小时恶心几率显著降低,止吐药需求更少。
  • 两组呼吸抑制、呕吐、头晕、瘙痒、头痛和镇静无差异。

核心结论

  • 他喷他多在腹腔镜子宫切除术后24小时内镇痛效力与羟考酮相似,但恶心显著更少。

主要发现

  • 术后1小时静息NRS评分:他喷他多组4.4(95%CI 3.8-5.0),羟考酮组4.6(95%CI 3.8-5.3)。
  • 24小时随访期间静息和咳嗽NRS组间无统计学显著差异(P=0.857和P=0.973)。
  • 口服 rescue 药物平均剂量组间相似(P=0.914)。
  • 他喷他多组术后2和3小时恶心几率显著更低(P=0.040,P=0.020),止吐药需求更少。
  • 呼吸抑制、呕吐、头晕、瘙痒、头痛或镇静无差异。

临床怎么用

  • 对于腹腔镜子宫切除术后多模式镇痛,他喷他多可作为羟考酮的替代选择,尤其关注恶心风险时。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tapentadol is an opioid, which acts as a μ-opioid receptor agonist and inhibits noradrenaline reuptake in the central nervous system. This dual mechanism of action results in synergistic analgesic effects and potentially less side effects. This has been shown in treatment of chronic pain but postoperative studies are sparse. OBJECTIVES: The main aim was to compare the analgesic effect of tapentadol with oxycodone after laparoscopic hysterectomy. Opioid side effects were recorded as secondary outcomes. DESIGN: Randomised, blinded trial. SETTING: Single-centre, Oslo University Hospital, Norway, December 2017 to February 2019. PATIENTS: Eighty-six opioid-naïve American Society of Anesthesiologists physical status 1 to 3 women undergoing laparoscopic hysterectomy for nonmalignant conditions. INTERVENTION: The patients received either oral tapentadol (group T) or oxycodone (group O) as part of multimodal pain treatment. Extended-release study medicine was administered 1 h preoperatively and after 12 h. Immediate-release study medicine was used as rescue analgesia. MAIN OUTCOME MEASURES: Pain scores, opioid consumption and opioid-induced side effects were evaluated during the first 24 h after surgery. RESULTS: The groups scored similarly for pain at rest using a numerical rating scale (NRS) 1 h postoperatively (group T 4.4, 95% CI, 3.8 to 5.0, group O 4.6, 95% CI, 3.8 to 5.3). No statistically significant differences were found between the groups for NRS at rest or while coughing during the 24-h follow-up period (P = 0.857 and P = 0.973). Mean dose of oral rescue medicine was similar for the groups (P = 0.914). Group T had significantly lower odds for nausea at 2 and 3 h postoperatively (P = 0.040, P = 0.020) and less need for antiemetics than group O. No differences were found for respiratory depression, vomiting, dizziness, pruritus, headache or sedation. CONCLUSION: We found tapentadol to be similar in analgesic efficacy to oxycodone during the first 24 h after hysterectomy, but with significantly less nausea. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03314792.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Comelon M, Raeder J, Drægni T, et al. Tapentadol versus oxycodone analgesia and side effects after laparoscopic hysterectomy: A randomised controlled trial. Eur J Anaesthesiol. 2021. PMID: 33428347. doi:10.1097/EJA.0000000000001425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。